Sarepta Therapeutics
SRPT
#1466
Rank
ยฃ9.24 B
Marketcap
ยฃ96.93
Share price
0.09%
Change (1 day)
-0.65%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ1.11 B

According to Sarepta Therapeutics 's latest financial reports the company has ยฃ1.11 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sarepta Therapeutics - Cash on Hand chart (from 1997 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ1.31 B-19.99%
2022-12-31ยฃ1.64 B5.18%
2021-12-31ยฃ1.56 B10.1%
2020-12-31ยฃ1.42 B67.54%
2019-12-31ยฃ0.84 B-7.88%
2018-12-31ยฃ0.92 B15.23%
2017-12-31ยฃ0.79 B209.95%
2016-12-31ยฃ0.25 B98.52%
2015-12-31ยฃ0.12 B-3.97%
2014-12-31ยฃ0.13 B-13.16%
2013-12-31ยฃ0.15 B34.07%
2012-12-31ยฃ0.11 B352.03%
2011-12-31ยฃ25.67 M17.59%
2010-12-31ยฃ21.83 M-27.4%
2009-12-31ยฃ30.07 M277.93%
2008-12-31ยฃ7.95 M-36.63%
2007-12-31ยฃ12.55 M-25.8%
2006-12-31ยฃ16.92 M-37.97%
2005-12-31ยฃ27.28 M168.17%
2004-12-31ยฃ10.17 M-52.01%
2003-12-31ยฃ21.2 M76.19%
2002-12-31ยฃ12.03 M-31.84%
2001-12-31ยฃ17.65 M-17.95%
2000-12-31ยฃ21.51 M199.7%
1999-12-31ยฃ7.17 M40.44%
1998-12-31ยฃ5.11 M-52.29%
1997-12-31ยฃ10.71 M511.52%
1996-12-31ยฃ1.75 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ2.11 B 89.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.79 B-28.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.98 B-11.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.20 B-81.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.99 B 79.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.83 B-25.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.95 B-14.63%๐Ÿ‡บ๐Ÿ‡ธ USA